Jana G Hashash, MD, MSc
@JHashashMD
Followers
2K
Following
6K
Media
73
Statuses
444
Assoc Prof of Med, GI with IBD focus @MayoClinic 🐊 | via @AUB_Lebanon @PittGIM @PittGILiverNutr | Chair of @AmerGastroAssn CPUC | ❤️ Research to 📈👫 Outcome
Florida, USA
Joined March 2019
CLEAR-IE - largest multicenter registry on percutaneous mechanical aspiration in R infective endocarditis now published in @JACCJournals - high procedural success, 93% neg blood cx, adverse events likely related to complications from IE esp hypoxia and shock - Prospective studies
18
61
182
Oncall w several #IBD pts getting admitted & thank goodness our new #GIFellow from @USF says he learned from @jensemineriomd ⚡️at USF! So relieved 😌. Then I realize how nice it is that we teach our future generations and they us. @CrohnsColitisFn @MN_GIMD @DCharabaty @JHashashMD
1
1
15
Monitoring Inflammatory Bowel Disease Activity: When, How, and Why Jill Gaidos, MD, FACG & Jana Hashash, MD, MSc, FACG 📕 https://t.co/uE3zJs5qNk
@JillGaidosMD @JHashashMD @MLongMD @JasmohanBajaj
2
68
127
🍁Kicking off the fall w 🎥 series focused on #IBD trials 🎯How to incorporate trials in your practice @JHashashMD 8/25 🎯New drugs & RCTs creating a buzz in the IBD @bruce_sands1 9/8 & 9/15 Support by edu grants @abbvie @JNJInnovMed @TakedaPharma 📌Where are you in your🩺
2
8
18
Thank you @DDS_Journal for highlighting our work on BAS & pouchitis @AlsakarnehSaqr @FarrayeIBD ✅BAS not inferior to abx in nonresponse or early relapse (aOR=0.94, p=0.34) ✅ BAS ⬇️ recurrent pouchitis (aHR: 0.57; p<0.001) and ⬆️ time to recurrent pouchitis (p<0.001)
Alsakarneh et al retrospectively studied the response of patients with pouchitis and resulting from IBD surgery, finding that treatment with bile acid sequestrants was noninferior or possibly superior to the current standard, antibiotic treatment. https://t.co/1TdUKUwsjd
3
6
24
Thank you to @MN_GIMD @jensemineriomd & course directors for an incredible weekend full of learning 👩🏫 👨🏫 and fun 🎉 with friends and colleagues @AdventhealthCFL Updates in GastroHep Conference! ✅ upper GI ✅ GLP1 💉 ✅ IBD/colon 🔥 ✅ liver ✅ AE ✅ AI 🖥️
2
2
48
@JHashashMD @AdventHealthCFL @MN_GIMD @DrHasan_Orlando @jensemineriomd @nyulangone Thank you @JHashashMD ☺️ It takes one to know one!!👑👑
0
1
2
3
4
26
High-yield talk at #GIHEUpdates2025! @JHashashMD delivered a masterclass on Inpatient IBD Management: 💡 Key pearls: ➡️ Day 0–3: Steroids + close monitoring (CRP daily, early scope). ➡️ Day 3–5: Escalate to rescue therapy if no response. ➡️ Hyperbaric oxygen shows promise in
0
5
19
That’s a winning team right there #IBD @JHashashMD from @MayoClinic Erin from MUSC and Jennifer Seminero wow 🙌🥇🏅
⭐️✨🌟IBD updates from leading experts and faboulois speakers on inpatient IBD treatment, updates in UC and CD management Drs.Hashash,Seminerio and Forster🌟💫✨ @AdventHealthCFL #GIHEPupdates2025 ⭐️ Esp happy to see all #womeningi lineup!!! 🙌🏼🙌🏼
0
1
5
@jensemineriomd @AdventHealth @IBD_DrEMF @AasmaShaukatMD @MN_GIMD @JHashashMD What a great meeting. Thank you for including @MayoClinicFLGIH faculty @JHashashMD @ibdgijami
0
2
15
Gaining the Upper Hand – Upadacitinib for Crohn’s Disease with Ileostomy: A Real-World Gap Addressed. https://t.co/ERVFtnZ1ie . My invited commentary on https://t.co/23ShnuMGns, just published in @DDS_Journal. @LaurenLoebMD @FarrayeIBD @EdwardLoftus2 @ibdgijami @JHashashMD
link.springer.com
Digestive Diseases and Sciences - Recent studies have established a role for Janus kinase (JAK) inhibitors in the management of patients with inflammatory bowel disease. However, these studies...
1
4
13
Join us for the Mayo Clinic Florida Internal Medicine Residency open house webinar on Tuesday, Sept 2; 4p-5p EST👍 Zoom registration: https://t.co/zSUAwOnf1W Submit Slido question prior: https://t.co/I6UJ9o4k0o We look forward to welcoming you! @MayoFL_IMRES 👍👍👍
mc-meet.zoom.us
Zoom is the leader in modern enterprise video communications, with an easy, reliable cloud platform for video and audio conferencing, chat, and webinars across mobile, desktop, and room systems. Zoom...
0
4
27
Join us for our 2nd @Mayoclinic #IBD Conference in ☀️🏖️ Florida 🐊 @MayoClinicFLGIH 📍Mayo FL 🗓️ Saturday, Nov 8 💻 Virtual option available ➕🩻 bonus Friday session with ✋🤚 on IUS session 📝👉 https://t.co/vTTuS00oTL
@FarrayeIBD @ibdgijami @JGubatanMD @CrohnsColitisFn
1
15
59
Grateful for @JillGaidosMD spending the day with us at @MayoClinicFLGIH as #IBD visiting professor Sharing updates in microscopic colitis at @BGFoundation904 #GUTClub and updates in #T2T with Mayo team Not 📸 @FarrayeIBD who dialed in from 🎣 vacation 🎉 @JHashashMD #HBD
2
4
27
I was fortunate to receive an @IFFGD Travel Award which I used to attend the annual @ANMSociety meeting. Off to a great start with lectures from giants in the field of motility. Thank you to @MayoClinicFLGIH for the opportunity to attend 🙏#ANMS2025
1
1
13
Happy to see our work published @APandT ‼️ ✅Isolated #PSC - even without #IBD - is an independent risk factor for #CRC! Hope it sparks further research and screening guidelines 🙏🏻 📖: https://t.co/TEIEGIMUrJ Grateful to continue working with the genius team @AasmaShaukatMD
3
18
91
Check out practical advice 📝 on Monitoring Inflammatory Bowel Disease Activity: When, How, and Why In @AmCollegeGastro @AmJGastro with @JillGaidosMD ✅ for: 🚽🩸Clinical response and remission 🧪💩💉Biochemical 🧐🔎🔬Endoscopic 🩻 Radiographic https://t.co/bJQyNPJnvh
1
35
78